• PNS11 Changes in the Latest Chinese Guidelines for Pharmacoeconomic Evaluations

    Sep 1, 2020, 00:00

  • PBI5 Future Trends on the Biosimilar Uptake in China, JAPAN, the US, the EU4 and the UK

    Sep 1, 2020, 00:00

  • PCN41 Cost-Effectiveness of Pembrolizumab in Combination with Chemotherapy in the 1ST LINE Treatment of Metastatic NSCLC in Taiwan

    Sep 1, 2020, 00:00

  • Did You Get What You Wanted? Patient Satisfaction and Congruence Between Preferred and Perceived Roles in Medical Decision Making in a Hungarian National Survey

    Sep 1, 2020, 00:00

  • PDB5 Assesment the Quality of Life in Children with Type 1 Diabetes

    Sep 1, 2020, 00:00

  • PMH7 Depression and Insomnia at Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • PCN70 Budget Savings from Patent Expiration of Cancer Drugs in South Korea

    Sep 1, 2020, 00:00

  • PRS21 The Complexity and Medical Resources for COPD Patients in China

    Sep 1, 2020, 00:00

  • Making Connections and Measuring Performance: Bibliometric Analysis of Multi-Attribute, Preference-Based Health-Related Quality of Life Research in South Africa

    Sep 1, 2020, 00:00

  • PCN105 Investigating Medical Utilization in Ductal Carcinoma in Situ (DCIS) Women: A Real-World Data Analysis

    Sep 1, 2020, 00:00

  • PDB3 SGLT2 Inhibitors and Risk of Diabetic Ketoacidosis in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PCN21 Disease Burden of Multiple Myeloma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS33 Developing and Adopting Regulatory Scien Experiences of Drug Regulatory Authorities in China, United States, European Union, and JAPAN

    Sep 1, 2020, 00:00

  • PMU7 Drug-Drug Interaction ( DDI ) Pharmacoeconomic Studies of Waste. Experience of a Single Institution Based on Rwd at a Private Health Insurance in LATAM

    Sep 1, 2020, 00:00

  • PDB19 Estimating National Burden of Disease Due to Type 2 Diabetes Considering Complications in Korea

    Sep 1, 2020, 00:00

  • PMH3 Desogestrel: Does IT Cause Severe Psychiatric Disorders, a Retrospective Analysis of FDA Adverse Event Reporting System and Eudravigilance

    Sep 1, 2020, 00:00

  • PNS40 The Implementation of Volume-Based Drug Procurement Policy in China

    Sep 1, 2020, 00:00

  • PIN20 Study on Disease Treatment Preference and Willingness Payment in Hepatitis C Patients

    Sep 1, 2020, 00:00

  • PRO16 Healthcare Resource Utilization (HCRU) in Patients with Generalized Pustular Psoriasis (GPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PBI1 Comparison of the Combination of Recombinant Follicle-Stimulating Hormone and Recombinant Luteinizing Hormone Protocol Versus Human Menopausal Gonadotropin Protocol in Controlled Ovarian Stimulation: A Systematic Review and Meta-Analys ...

    Sep 1, 2020, 00:00

  • PRO8 Analysis of Health Authorities Collaboration for Orphan Drug Designation and Their IMPACT on the Growth of Orphan Drug Market

    Sep 1, 2020, 00:00

  • PSS5 Disease Burden of Rvo-ME in China——a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PIN16 Disease Burden of Progressive Chronic Hepatitis B in China

    Sep 1, 2020, 00:00

  • PIH7 Cost of Illness of Inpatient Pediatric Pneumonia Patients Hospitalized in Yogyakarta Indonesia

    Sep 1, 2020, 00:00

  • Prioritization of Medicine Importation by the Private Sector in Sudan: Evidence from a Data Analysis, 2012-2015

    Sep 1, 2020, 00:00

  • PCN84 Comparison of Treatment Among Peripheral T-CELL Lymphoma and Cutaneous T-CELL Lymphoma in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PCN11 The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC) Patients and Burden of Advanced HCC across Hong Kong, Singapore and Thailand

    Sep 1, 2020, 00:00

  • PNS46 Exploration of the Weight-Loss Management Service at Community Pharmacy in Malaysia

    Sep 1, 2020, 00:00

  • PSU12 Landscape Analysis of Analgesics Utilization during Perioperative Period in China

    Sep 1, 2020, 00:00

  • PDG4 Cost-Utilities Analysis of First LINE Treatments on Advanced STAGE EGFR Positive in NON-SMALL CELL LUNG Cancer Patients in Taiwan

    Sep 1, 2020, 00:00

  • PMD13 Estimating the Cost of Treating Myasthenia Gravis Patient in a Single Public Hospital

    Sep 1, 2020, 00:00

  • PIH5 Clinical and Economic Evaluation of ORAL Versus Intravenous Ibuprofen Therapy in Preterm Infants with Patent Ductus Arteriosus in the Neonatal Intensive Care Unit in Qatar

    Sep 1, 2020, 00:00

  • PND21 BUDGET IMPACT OF ROTIGOTINE ON CHINESE NATIONAL MEDICAL FUND PAYMENT FOR PARKINSON'S DISEASE

    Sep 1, 2020, 00:00

  • PCN83 Real-World Prescription Patterns of HER2+/HR- Metastatic Breast Cancer Patients after Ado-Trastuzumab Emtansine Approval: A Retrospective Cohort Study Using Electronic Health Record DATA with Cancer Registries

    Sep 1, 2020, 00:00

  • PDB26 Knowledge, Attitude and Practices of Insulin Self-Administration Techniques Among Diabetic Patients

    Sep 1, 2020, 00:00

  • PDG3 Comparison of Pharmacoeconomic Evaluation Guidelines in Korea, JAPAN and China

    Sep 1, 2020, 00:00

  • PUK7 Budget Impact Of A New Mobile Application Reimbursement Strategy For Diabetic Patients In Andhra Pradesh (India)

    Sep 1, 2020, 00:00

  • PRO11 Policy Initiatives to Facilitate the Patient Access to Orphan Drugs in China

    Sep 1, 2020, 00:00

  • PBI7 Comparison of Biosimilar Policies between Key Countries in ASIA, EU and USA

    Sep 1, 2020, 00:00

  • PMU15 Utilization and Spending of Low-VALUE Healthcare UNDER a National Health Insurance Program: A Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PND10 Assessing the Cost of Treatment for Myasthenia Gravis Crisis Patients in Australia

    Sep 1, 2020, 00:00

  • PNS3 Managed Entry Agreements: The European Experience and the Potential in JAPAN

    Sep 1, 2020, 00:00

  • PCV4 Review On:-Cardiovascular Risk Reduction With Icosapent Ethyl For Hypertriglyceridemia

    Sep 1, 2020, 00:00

  • PUK3 Cost Consequence Analysis of Remote Monitoring with the Homechoice Claria® with Sharesource® Platform for Automated Peritoneal Dialysis Patients in the Australian Setting

    Sep 1, 2020, 00:00

  • PAM2 Cost-Effectiveness of Thread Embedding Therapyfor Patients with Chronic, Herniated Lumbar Disk

    Sep 1, 2020, 00:00

  • PMU2 Will Vaccinating an Aging Population Lead to Good Return on Investment?

    Sep 1, 2020, 00:00

  • PMH13 Children with Computer GAME Addiction Benefit from Visuospatial Training

    Sep 1, 2020, 00:00

  • PCN56 Addressing the Credibility GAP of Real-World Evidence Generation in Southeast ASIA: An Analysis of 200 Articles over 10 YEARS

    Sep 1, 2020, 00:00

  • PDB15 Cost-Effectiveness of Gliclazide MR-Based Intensive Glucose Control Versus Standard Glucose Control in Type 2 Diabetes Mellitus: Pharmacoeconomic Analysis in Thailand Based on the Advance Trial MODEL

    Sep 1, 2020, 00:00

  • PCV28 The EQ-5D-5L Is More Discriminative Than The EQ-5D-3L In Patients With Cardiovascular Diseases: A Multi-Ethnic Asian Study

    Sep 1, 2020, 00:00

  • PMU29 Real World DATA Availability and Quality in ASIA Pacific. Assessment and Implications for Research and Healthcare Decision-Making

    Sep 1, 2020, 00:00

  • PIN4 Associations between Thromboprophylaxis and Ventilator-Associated Events Among Patients Receiving Mechanically Ventilated

    Sep 1, 2020, 00:00

  • PCN3 Knowledge of Treatment Assignment and Clinician Adverse Event Reporting: An Evaluation in Multiple Myeloma

    Sep 1, 2020, 00:00

  • PRS10 Impact of Tobacco Smoking before Pregnancy on Quality of Life of Pregnant Women: A National Cross-Sectional Study

    Sep 1, 2020, 00:00

  • PIN44 Benefit Design Considerations during Emergencies: Lessons from Covid 19

    Sep 1, 2020, 00:00

  • PMS8 Estimating the Future Clinical and Economic Benefits of Improving Osteoporosis Diagnosis and Treatment Rates Among Women in South Korea: A Simulation Projection Model from 2020-2040

    Sep 1, 2020, 00:00

  • PIH6 Economic Evaluation of the Automated Resuscitator Device for Asphyxiated Neonates in Tertiary LEVEL Healthcare Setting in India

    Sep 1, 2020, 00:00

  • PCV29 Iqvia Hospital Information System DATA Secondary Use for Outcome Identification to Assess the Validity of Definitions

    Sep 1, 2020, 00:00

  • PCN6 Thromboembolic Events Among Cancer Patients Treated with Chemotherapy at Adult Oncology Unit of Tikur Anbessa Specialized Hospital: A Retrospective CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PDG1 Prevalence and Determinants of Serious Spontaneously Reported Adverse Drug Events Among Three Outpatient Care Settings in Ghana: Findings and Implications

    Sep 1, 2020, 00:00

  • PMD12 Key Considerations of VALUE Assessment Frameworks for Medical Devices and Diagnostics in ASIA Pacific

    Sep 1, 2020, 00:00

  • PCN51 Disease Burden of Mantle CELL Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • Financial Disclosure Information

    Sep 1, 2020, 00:00

  • PCN75 Characterization of Oncology Managed Entry Agreements (MEA) in APAC and Assessment of Payer Considerations

    Sep 1, 2020, 00:00

  • PUK2 Assessing Mortality Risk and Renal Outcomes in Chronic Kidney Disease Patients Treated with Sglt-2 Inhibitors or DPP-4 Inhibitors: A Real-World Study

    Sep 1, 2020, 00:00

  • PDB16 Identifying Prevalence and Risk Factors of Poor Glycemic Control Among Diabetic Patients in a Central RURAL Province of Saudi Arabia

    Sep 1, 2020, 00:00

  • Assessing Patient Knowledge of Asthma Using a Newly Validated Tool

    Sep 1, 2020, 00:00

  • PCV5 Cost-Effectiveness Analysis of Apixaban in Treatment of Atrial Fibrillation: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS36 Cost-Benefit Analysis of Dental Prevention Programs for Children in Taiwan

    Sep 1, 2020, 00:00

  • PMH8 A DEEP Learning Approach for Predicting Onset of Depressive Disorder Using Health Insurance Claims DATA

    Sep 1, 2020, 00:00

  • PSU4 Cost Comparison and Budget IMPACT MODEL for Radical Prostatectomy in England

    Sep 1, 2020, 00:00

  • PDG18 Availability, Cost and Affordability of Selected Antibiotics and Antiviral Medicines Against Infectious Diseases from 2013 to 2019 in Nanjing, China

    Sep 1, 2020, 00:00

  • PIH16 Use of Tripod Checklist to Evaluate the Reporting Quality of Prognostic Prediction Models for Obstetric Care

    Sep 1, 2020, 00:00

  • PCN78 Cost Comparison of Administering ORAL Compared to Intravenous paclitaxel for Patients with Advanced Gastric Cancer in South Korea: A MICRO-Costing Study

    Sep 1, 2020, 00:00

  • PIH3 Pharmacoeconomic Evaluation of ORAL Ibuprofen Versus Intravenous Ibuprofen in Preterm Infants with Patent Ductus Arteriosus in the Neonatal Intensive Care Units in Qatar

    Sep 1, 2020, 00:00

  • PNS51 The Role of Patients in Health Technology Assessment Process - Experience of Taiwan

    Sep 1, 2020, 00:00

  • PND25 Identification of NOVEL Drug Targets and Exploring Drug Repurposing Avenues for Amyotrophic Lateral Sclerosis

    Sep 1, 2020, 00:00

  • PDG10 An Economic Evaluation of Tofacitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis in Singapore

    Sep 1, 2020, 00:00

  • PMU17 Health Technology Assessment for Procedures: The Evaluation of Innovation in JAPAN

    Sep 1, 2020, 00:00

  • PIN5 Evaluating Treatments and Corresponding Mortality Rates in Patients with Acinetobacter Baumannii Infections

    Sep 1, 2020, 00:00

  • PND3 Patient-Reported Outcomes Following Neuromanual Therapy For Carpal Tunnel Syndrome- Comparison Of Four Patient Healthcare Outcome Measures In A Randomized Clinical Trial

    Sep 1, 2020, 00:00

  • PDB28 A Real-World Effectiveness of Udca Added to Oha on Glycemic Control in Type 2 Diabetes Patients with LIVER Disease

    Sep 1, 2020, 00:00

  • PCN74 Analyze Oncology Drug Price Change in the Chinese Market through National Reimbursement Drug LIST Negotiation

    Sep 1, 2020, 00:00

  • PCN88 HTA Evaluations of Oncology Drugs in APAC - Comparison of Trends and Drivers of Success in 5 Countries

    Sep 1, 2020, 00:00

  • PNS54 Competencies Required in the Profile of the Health Professional for Management and Assistance in Telemedicine Programs: A Review of the Literature

    Sep 1, 2020, 00:00

  • PIN14 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 65 YEARS and Older in Korea

    Sep 1, 2020, 00:00

  • PNS30 IMPACT of Cigarette Tax on Youth Smoking in Taiwan

    Sep 1, 2020, 00:00

  • PUK4 Cost-Effectiveness of Robotic-Assisted Partial Nephrectomy

    Sep 1, 2020, 00:00

  • PNS5 Comparison of Instruments Valuing Health-Related Productivity Losses

    Sep 1, 2020, 00:00

  • PNS2 Voice Technology - an Opportunity to Broaden Participation in Patient Reported Outcomes Research

    Sep 1, 2020, 00:00

  • PDG27 The Complexity and Cost of Drug Regimens for Hypertensive Patients in China

    Sep 1, 2020, 00:00

  • PCN43 Disease Burden of NON-SMALL CELL Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN7 The Cost Effectiveness Analysis of a Nonavalent Vaccine in China

    Sep 1, 2020, 00:00

  • The Cost-Effectiveness of Abdominal Aortic Aneurysm Screening in Estonia

    Sep 1, 2020, 00:00

  • PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

    Sep 1, 2020, 00:00

  • PMS2 Disease Burden of Subsequent Fracture in Osteoporosis Patients in South Korea

    Sep 1, 2020, 00:00

  • PNS29 IMPACT of Pharmacoeconomic Evaluation Guidelines: A Systematic Review of Reporting Quality of Pharmacoeconomic Evaluations for NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PIN26 Assessment Of Influence Of Education To Parents Towards Completion Of Vaccination : A Randomised Controlled Study

    Sep 1, 2020, 00:00

  • PIN24 Disease Burden of Progressive Chronic Hepatitis C in China

    Sep 1, 2020, 00:00

  • PMH15 Children with Deficit in Executive Abilities Have a Risk for Emerging Weakness in Grammar Understanding

    Sep 1, 2020, 00:00

  • PND27 Valuing Health States Using Discrete Choice Experiment: Case of Cerebral Palsy

    Sep 1, 2020, 00:00

  • PRS9 Economic Burden of Adult Patients with Asthma Using a CROSS-Sectional Analysis of Survey DATA in ASIA and the U.S

    Sep 1, 2020, 00:00

  • The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect? [Editor's Choice]

    Sep 1, 2020, 00:00

  • PND7 Cost-Effectiveness of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Kazakhstan

    Sep 1, 2020, 00:00

  • PNS56 Effect of the Recall Period for Estimating Inpatient out-of-Pocket Expenditures: Validation Study in Vietnam

    Sep 1, 2020, 00:00

  • PRS5 An Environment IMPACT Analysis of the Use of Respimat RE-Usable for the Treatment of Chronic-Obstructive Pulmonary Disorder (COPD) in South-EAST ASIA and South Korea

    Sep 1, 2020, 00:00

  • PDG19 Status of Published Pharmacoeconomic Evidence on Monoclonal Antibodies Reimbursed in China

    Sep 1, 2020, 00:00

  • PMS5 Incidence and Risk Factors for Subsequent Osteoporotic Fracture: A Nationwide Cohort Study in South Korea

    Sep 1, 2020, 00:00

  • PIN8 Analysis of Potential Cost-Savings after Introduction of 0.1% Polihexanide/Betaine Solution for Chronic Wounds in Reimbursement Healthcare System of Korea

    Sep 1, 2020, 00:00

  • PNS13 Assessment of Satisfaction with New Competencies and Roles of Nurses in the Framework of Nursing Reform in Kazakhstan

    Sep 1, 2020, 00:00

  • PND12 Vagus Nerve Stimulation Versus ANTI-Epileptic Drug in Chinese Patients with Drug-Resistant Epilepsy: A Cost–Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PMD14 Economic Analysis to Evaluate IMPACT of Prostheses Choice in Primary TOTAL Knee Arthroplasty

    Sep 1, 2020, 00:00

  • PIN35 Evaluation of Effectiveness of Knowledge Transfer of Antimicrobial Resistance to Hong Kong Elderly: A Quasi-Experiment

    Sep 1, 2020, 00:00

  • PNS68 Valuating the CHILD Health Utility 9-Dimention in JAPAN: Results from a Nation-Wide School-Based Survey

    Sep 1, 2020, 00:00

  • PNS65 Comparison of Quality of Life and Burden of Lower Back PAIN Among Patients with and without a Diagnosis in Korea, Taiwan, JAPAN and USA

    Sep 1, 2020, 00:00

  • PIH14 Perception of Seriousness, Knowledge, and Willingness to Pay for Cervical Cancer Screening Among Women in Yogyakarta Province, Indonesia

    Sep 1, 2020, 00:00

  • PGI2 Quantitative Evaluation to Efficacy and Safety of Biosimilar of Infliximab in Inflammatory Bowel Diseases: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PBI4 The ISSUE of Patient CO-Pay and Biosimilars in JPN: Is IT Really an ISSUE?

    Sep 1, 2020, 00:00

  • PDG14 Evaluating Accessibility of Essential Medicines in Indonesia: A Survey on Availability and Price in Public and Private Health Sectors

    Sep 1, 2020, 00:00

  • PCN101 Healthcare Resource Utilization, Costs, and Clinical Outcomes in Patients with Triple-Negative Breast Cancer in Northern Thailand: A Real World Evidence Using Electronic Health Records

    Sep 1, 2020, 00:00

  • PRS8 The Cost Effectiveness Analysis of SIX COPD Treatment Strategies in China

    Sep 1, 2020, 00:00

  • PND19 Economic and Social Factors Affecting Healthcare Expenditure for Households with Cerebrovascular Diseases

    Sep 1, 2020, 00:00

  • PMS1 Economic Outcomes of Ankylosing Spondylitis Patients Initiating Biologic Therapy in Taiwan - a Population-Based Analysis

    Sep 1, 2020, 00:00

  • PUK5 Remaining Waitlisted for a Superior Quality Kidney; An Economic Evaluation of Contemporary Transplant Practice

    Sep 1, 2020, 00:00

  • PDB9 Budget IMPACT Analysis of Empagliflozin in Type-2 Diabetes Patients with High Cardiovascular Risk in South Korea Based on Empa-REG OUTCOME® Trial: HIRA(HEALTH INSURANCE REVIEW ASSESSMENT SERVICE)-NPS (NATIONAL PATIENTS SAMPLE) Databas ...

    Sep 1, 2020, 00:00

  • PIN18 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in New Zealand

    Sep 1, 2020, 00:00

  • PCN5 Real-World Incidence and Management of Adverse Events (AE) in Patients with NON-Metastatic Castrate-Resistant Prostate Cancer Receiving Apalutamide or Enzalutamide

    Sep 1, 2020, 00:00

  • PCN39 Cost-Effectiveness of Brentuximab Vedotin for Relapsed or Refractory Systemic Anaplastic Large-CELL Lymphoma in China

    Sep 1, 2020, 00:00

  • PMU14 China's 2019 National Reimbursement Drug LIST Update: Implications on Global and Local Manufacturer Strategy

    Sep 1, 2020, 00:00

  • PND14 Identifying Patients with RARE Refractory Epilepsies in Japanese Health Databases: Feasibility for a Burden of Illness Study

    Sep 1, 2020, 00:00

  • PDB20 Clinical Outcomes Among Patients with Hyperkalemia in China: A Population-Based Retrospective Study

    Sep 1, 2020, 00:00

  • PCN71 Comparing the International Price of Anticancer Drugs and Improving Their Accessibility in South Korea

    Sep 1, 2020, 00:00

  • PCV23 Budget IMPACT Analysis of Sacubitril Valsartan for Heart Failure Treatment in Indonesia

    Sep 1, 2020, 00:00

  • PMS17 Usability Testing of a Patient Engagement Digital Platform for TOTAL Knee Arthroplasty (TKA) Patients in JAPAN

    Sep 1, 2020, 00:00

  • PMU13 Defining the ROLL out Strategy for UHC Benefits: Philhealth's Benefit Development PLAN

    Sep 1, 2020, 00:00

  • PBI3 The Economic Evaluation Of Clopidogrel In Antiplatelet Therapy Guided By CYP2C19 Gene Polymorphism In The Treatment Of Patients With Coronary Heart Disease

    Sep 1, 2020, 00:00

  • PIN21 Cost-Effectiveness of Ceftazidime-Avibactam for Gram-Negative Infections with Limited Treatment Options in China

    Sep 1, 2020, 00:00

  • PNS31 Increased Cigarette Taxes and Quitting Behavior Among Adults

    Sep 1, 2020, 00:00

  • PMH1 MODEL Based Pharmacoeconomic Evaluation of Medication for Depression Disorder: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS10 Economic Evaluation in the Philippines before the Era of Mandatory Health Technology Assessment: A Systematic Review

    Sep 1, 2020, 00:00

  • PCN42 A Real World Comparison of Utility Values Derived from a Discrete Choice Experiment Versus Patient Reported Outcomes in Clinical Trials

    Sep 1, 2020, 00:00

  • PDB12 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • Valuing Health State: An EQ-5D-5L Value Set for Ethiopians [Editor's Choice]

    Sep 1, 2020, 00:00

  • PCN4 Aromatase Inhibitors and Bisphosphonate Use in Postmenopausal Women with Hormone-Receptor Positive Breast Cancer in Hong Kong

    Sep 1, 2020, 00:00

  • PRO14 Quality of Life in Patients with Gaucher Disease and Factors Associated: A Study on Adult Patients in China

    Sep 1, 2020, 00:00

  • PNS64 Landscape Analysis of Studies in Asia Eliciting Patient Preferences for Therapeutic Interventions

    Sep 1, 2020, 00:00

  • PIN19 Direct Medical Cost of HIV/AIDS Treatment in Vietnam

    Sep 1, 2020, 00:00

  • PNS24 Willingness-to-Pay Thresholds Applied for Health Economic Analyses in Oncology in China: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PNS7 A Systematic Review of Cost Utility Studies Conducted from an Indian Perspective

    Sep 1, 2020, 00:00

  • PMD8 Mortality after Use of paclitaxel-Based Devices in Peripheral Arteries : A Real-World Analysis

    Sep 1, 2020, 00:00

  • PCN2 The Effect of IMAGE-Guided Radiotherapy on Cancer Patients' Survival

    Sep 1, 2020, 00:00

  • PDG25 Drug Therapy Problem and Contributing Factors in Ethiopia: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PSU15 A Cost Analysis of OPEN, Laparoscopic and ROBOT-Assisted Hysterectomy for Endometrial Cancer in Korea

    Sep 1, 2020, 00:00

  • PRO9 Orphan Drug Pricing in JAPAN Since Reform

    Sep 1, 2020, 00:00

  • PDB22 Drug Related Problems in Type-2-Diabetes Mellitus with and without Cardiovascular Diseases: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN14 Disease Burden of Waldenstrom's Macroglobulinemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIH9 Quantification Of Sleep Quality Among Older Adults In The State Of Penang, Malaysia

    Sep 1, 2020, 00:00

  • PMU24 Using the Medication Adherence Reasons Scale (MAR-SCALE) to Identify the Reasons for Medication NON-Adherence Among Type 2 Diabetes, Migraine, and Depression Medication Users in JAPAN

    Sep 1, 2020, 00:00

  • PSU2 Clinical Outcomes and Economics Associated with Surgical Mitral Valve Replacement in Taiwan

    Sep 1, 2020, 00:00

  • PCN35 Out-of-Pocket Cost of Cancer Treatement: A Systematic Review for Literatures from Taiwan

    Sep 1, 2020, 00:00

  • PRS3 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in Australia

    Sep 1, 2020, 00:00

  • PMH11 Post Partum Depression:Prevalence, Risk Factors/Causes, Knowledge and Medication Use

    Sep 1, 2020, 00:00

  • PIN43 IMPACT of CRE Infections on Hospital LOS and Mortality in ASIA

    Sep 1, 2020, 00:00

  • PRS2 Impact Of Knowledge And Attitude On Antibiotic Used For Upperrespiratory Tract Infections At Burapha University 2019

    Sep 1, 2020, 00:00

  • PSS2 Modelling Disease Burden in Patients with Myopia in China in 2030

    Sep 1, 2020, 00:00

  • PUK6 Assessing Trend In Medical Expenditure And Measuring The Impact Of Health-Related Quality Of Life (HRQOL) On Medical Expenditure For U.S. Adults With Diabetes Associated Chronic Kidney Disease (CKD)Using 2002-2016 Medical Expenditure P ...

    Sep 1, 2020, 00:00

  • PCV14 A Real World Clinical and Economic Evaluation of a Chinese Traditional Medicine (SONGLINGXUEMAIKANG) in the Management of Hypertension Patients in China

    Sep 1, 2020, 00:00

  • PDB14 Cost-Effectiveness of Liraglutide Versus Exenatide, BOTH in Combination with Metformin for Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PRO15 A Brief Introduction of DATA Governance for Congenital Anomalies Based on the Xiamen Registry of Pregnant Women and Offspring (REPRESENT): A Population-Based, LONG-TERM and Follow-up Database

    Sep 1, 2020, 00:00

  • PSS3 Bioinformatics Analysis of Potential Targets for Drug Repurposing in Contact Eczema through Microarray Profiles

    Sep 1, 2020, 00:00

  • PIN10 Cost IMPACT Analysis for Antibiotic Coated VS. NON-Coated Central Venous Catheters in India

    Sep 1, 2020, 00:00

  • PNS32 Impoverishing Effects Of Out-Of-Pocket Health Expenditures In India

    Sep 1, 2020, 00:00

  • PIN46 Predicting Invasive Candidiasis in Intensive Care Units

    Sep 1, 2020, 00:00

  • PMH12 Trends in Use of Prescription, over the Counter, and Traditional Chinese Medicine for Mental Health Conditions in China, 2009 - 2017

    Sep 1, 2020, 00:00

  • PNS66 Content Validation of Translated Clinical Outcome Assessments Is Important: Recommendations from Experience in Japan and China

    Sep 1, 2020, 00:00

  • PCN47 Disease Burden of Gastric Cancer UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMU10 Representativeness of a National Patient-Reported Survey in Korea: The Korea National Health and Wellness Survey

    Sep 1, 2020, 00:00

  • PDG8 The Cost-Effectiveness of Direct-Acting Antivirals Coverage Policies for Patients with Hepatitis C VIRUS Infection in Taiwan

    Sep 1, 2020, 00:00

  • PMU3 Medical Cost for Children with Infantile Hemangiomas in Southern China: Investigation Based on Medical Record DATA

    Sep 1, 2020, 00:00

  • Productivity Loss in Patients With Chronic Diseases: A Pooled Economic Analysis of Hungarian Cost-of-Illness Studies [Editor's Choice]

    Sep 1, 2020, 00:00

  • PDG2 Survey of Usage of Molecular Targeted Drugs in LUNG Cancer Based on Claims DATA in JAPAN

    Sep 1, 2020, 00:00

  • PMH5 Assessing the IMPACT of New Policy for Patients with Mental Disorders on Cost of Drug Prescription: An Interrupted Time Series Analysis

    Sep 1, 2020, 00:00

  • PIN25 The IMPACT of Childhood Pneumococcal Conjugate Vaccine Immunisation on Pneumonia Admissions in Hong Kong: A Population-Based Interrupted Time Series Analysis from 2004-2017

    Sep 1, 2020, 00:00

  • PMU23 Measurement of Health-Related Quality of Life in Australians with Progressive Onset Multiple Sclerosis

    Sep 1, 2020, 00:00

  • PND1 Depression And Sleep Quality Of People At Faculty Of Pharmaceutical Sciences, Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • Copyright/Subscription

    Jun 3, 2020, 09:04

  • From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review

    May 1, 2020, 00:00

  • Inappropriate Rate of Admission and Hospitalization in the Iranian Hospitals: A Systematic Review and Meta-Analysis

    May 1, 2020, 00:00

  • Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

    May 1, 2020, 00:00

  • Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action

    May 1, 2020, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals

    May 1, 2020, 00:00

  • Translation, Cultural Adaptation, and Validation of Short-Form 6D on the General Population in Indonesia

    May 1, 2020, 00:00

  • The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

    May 1, 2020, 00:00

  • Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review [Editor's Choice]

    May 1, 2020, 00:00

  • Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF for Multi-Outcomes of Patients With Presumptive Pulmonary Tuberculosis in Thailand [Editor's Choice]

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • Cross-Cultural Adaptation and Psychometric Analysis of the Persian Version of the ICEpop CAPability Measure for Adults Capability Measure in the Iranian General Population

    May 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • »